Billionaires Holding MDCO

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 64.5M
    Shares Outstanding

  • 2.66B
    Market Cap

News & Insights

ABOUT

MDCO

The Medicines Company provides medical solutions for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous trans...

Berkshire Hathaway Inc.'s Biggest Win in 2016 So Far

NEWS

3 Big Moves That Warren Buffett Could Make Next

READ MORE